DetailsChartProfilRisikomatrixNachrichtenDokumente

Bellevue Biotech DT CHF/  CH0113817123  /

Fonds
NAV17.10.2024 Diff.-8,9700 Ertragstyp Ausrichtung Fondsgesellschaft
3.773,6699CHF -0,24% thesaurierend Aktien Swisscanto Fondsl. ▶
     
Chart for Bellevue Biotech DT CHF
  Titel   ISIN Performance Volatilität Sharpe Ratio
1. J.Henderson H.BioTech.F.IU2 LU1897414568 +47,61% 22,12% 2,01
2. Abaris Biotech.Opportunities A USD LU2210105313 +85,60% 41,06% 2,01
3. J.Henderson H.BioTech.F.H2 LU1897414485 +47,40% 22,09% 2,00
4. J.Henderson H.BioTech.F.A2 LU1897414303 +46,75% 22,12% 1,97
5. Janus Henderson Horizon Biotechnology Fund IU2 EUR LU2441282626 +43,27% 20,82% 1,92
6. Janus Henderson Horizon Biotechnology Fund H2 HEUR LU2441283277 +45,13% 22,19% 1,89
7. Janus Henderson Horizon Biotechnology Fund A2 EUR LU2441282899 +42,94% 21,15% 1,88
8. Abaris Biotech.Opportunities A EUR LU2210105669 +77,88% 39,85% 1,87
9. Janus Henderson Horizon Biotechnology Fund A2 HEUR LU2441282972 +44,12% 22,11% 1,85
10. Abaris Biotech.Opportunities A CHF LU2210124454 +77,71% 40,88% 1,82
...
72. Bellevue Biotech DT CHF CH0113817123 +15,12% 18,27% 0,65